13G Filing: Armistice Capital and Onconova Therapeutics Inc. (ONTX)

Page 5 of 9 – SEC Filing

CUSIP No 68232V306
Item 1. (a). Name of Issuer:
Onconova Therapeutics, Inc.
(b). Address of Issuer’s Principal Executive Offices:

375 Pheasant Run

Newtown, Pennsylvania 18940

United States of America

Item 2. (a). Name of Person Filing:

Armistice Capital, LLC

Armistice Capital Master Fund Ltd.

Steven Boyd

(b). Address of Principal Business Office, or if None, Residence:

Armistice Capital, LLC

510 Madison Avenue, 22nd Floor

New York, New York 10022

United States of America

Armistice Capital Master Fund Ltd.

c/o dms Corporate Services Ltd.

20 Genesis Close

P.O. Box 314

Grand Cayman KY1-1104

Cayman Islands

Steven Boyd

c/o Armistice Capital, LLC

510 Madison Avenue, 22nd Floor

New York, New York 10022

United States of America

(c) Citizenship:

Armistice Capital, LLC – Delaware

Armistice Capital Master Fund Ltd. – Cayman Islands

Steven Boyd – United States of America

(d).   Title of Class of Securities:
Common Stock, par value $0.01 per share
(e). CUSIP Number:
68232V306

Follow Traws Pharma Inc. (NASDAQ:TRAW)